CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | Birznieks Gunther SVP, Business Development | Grant or award | +125,000 | 330,980 | ||
| 2023-08-21 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −3,724 | $5.84 | $22K | 113,816 |
| 2023-08-10 | Mitchell Stephen Ray Director | Sale | −6,500 | $6.05 | $39K | 29,328 |
| 2023-07-28 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −412 | $6.30 | $3K | 122,514 |
| 2023-07-28 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −1,800 | $6.31 | $11K | 120,714 |
| 2023-06-15 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −16,000 | $6.29 | $101K | 122,926 |
| 2023-06-13 | Williams Timothy SVP & General Counsel | Sale | −14,600 | $6.56 | $96K | 88,913 |
| 2023-06-08 | Ward Anne Sempowski Director | Grant or award | +17,307 | 39,313 | ||
| 2023-06-08 | Ward Anne Sempowski Director | Grant or award · Stock Option (right to buy) | +33,960 | 33,960 | ||
| 2023-06-08 | Mitchell Stephen Ray Director | Grant or award | +17,307 | 35,828 | ||
| 2023-06-08 | Mitchell Stephen Ray Director | Grant or award · Stock Option (right to buy) | +33,960 | 33,960 | ||
| 2023-06-08 | Honore Tage Director | Grant or award | +17,307 | 43,715 | ||
| 2023-06-08 | Honore Tage Director | Grant or award · Stock Option (right to buy) | +33,960 | 33,960 | ||
| 2023-06-08 | DUGAN RICHARD W Director | Grant or award | +17,307 | 97,700 | ||
| 2023-06-08 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +33,960 | 33,960 | ||
| 2023-06-08 | Chrousos Phaedra Director | Grant or award | +17,307 | 42,238 | ||
| 2023-06-08 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +33,960 | 33,960 | ||
| 2023-03-15 | Honore Tage Director | Grant or award | +26,408 | 26,408 | ||
| 2023-03-15 | Honore Tage Director | Grant or award · Stock Option (right to buy) | +51,276 | 51,276 | ||
| 2023-03-03 | Williams Timothy SVP & General Counsel | Sale | −8,301 | $6.25 | $52K | 103,513 |
Page 5 of 8 · 153 trades